J Knee Surg 2011; 24(3): 185-190
DOI: 10.1055/s-0031-1284730
ORIGINAL ARTICLE

© Thieme Medical Publishers

Acoustic Emission Studies of Posterior Stabilized and Cruciate Retaining Knee Arthroplasties

Ran Schwarzkopf1 , Frederick J. Kummer1 , William L. Jaffe1
  • 1Department of Orthopaedics, NYU Hospital for Joint Diseases, New York, New York
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
01. August 2011 (online)

Preview

ABSTRACT

Different acoustic frequencies have been used to diagnose progression of osteoarthritis, gross pathology, and wear in knee prostheses. It is possible that detailed analysis of higher frequencies could detect and quantify the smaller geometric changes (asperities) that develop in articular prosthetic wear. In this study we evaluated the feasibility of using ultrasonic emission to determine total knee arthroplasty (TKA) type and time from implantation using a simple, handheld measurement system. We examined the ultrasound emission generated by similar designs of posterior stabilized (PS) and cruciate retaining (CR) total knee prostheses and native knees of 58 patients and 10 controls. The subjects were asked to sit, rise, sit again, and take five steps while recording the acoustic data from both knees. Acoustic emission analysis examined frequency distributions and power spectrums of the recorded signals, and their relations to prosthesis type and time from implantation. We screened 44 CR and 48 PS TKAs, as well as 24 native knees. Analysis of this data suggested a possibility of differentiating between type of implants, and a relation to time since implantation. Our data suggest that we might be able to assess the status and time from implantation of a TKA by acoustic emission signals. Further in vitro analysis of the relationship of wear to ultrasonic emission data are needed for accurate quantification of arthroplasty wear. A simple, in-office screening tool for TKA patients could indicate which patients require closer follow-up and monitoring due to risk of potential problems.

REFERENCES

Ran SchwarzkopfM.D. M.Sc. 

NYU Hospital for Joint Diseases

301 E 17th Street, New York, NY 10003

eMail: schwarzk@gmail.com